Patents by Inventor Richard Oryszczak
Richard Oryszczak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220354754Abstract: A foaming antiperspirant or deodorant composition comprising: a. an oil and water emulsion; b. a first blowing agent with at least 0.1% water solubility at 20° C.; and c. a second blowing agent with a water solubility of at most 0.01% at 20° C.Type: ApplicationFiled: May 2, 2022Publication date: November 10, 2022Inventors: David Frederick SWAILE, Barbara Marie MODAFARI, Jorge Max Sunkel, Jianwei ZHANG, Kerry Andrew VETTER, Richard ORYSZCZAK, Stephen J. PROVANCAL
-
Publication number: 20220354758Abstract: A foaming antiperspirant or deodorant composition comprising: a. an oil in water emulsion comprising: i. a first oil phase comprising one or more emollients; ii. a second oil phase comprising one or more emollients; wherein the second oil phase emollients have at most 5% solubility in the first oil phase emollients; iii. an antiperspirant or deodorant active; iv. one or more nonionic emulsifier; and v. a fragrance; and b. at most about 15%, by weight of the composition, of a blowing agent.Type: ApplicationFiled: May 2, 2022Publication date: November 10, 2022Inventors: David Frederick SWAILE, Barbara Marie MODAFARI, Jorge Max SUNKEL, Jianwei ZHANG, Kerry Andrew VETTER, Richard ORYSZCZAK, Stephen J. PROVANCAL
-
Publication number: 20070003499Abstract: Disclosed is a solid particulate antiperspirant salt comprising a mixture (or complex) of an enhanced efficacy aluminum-zirconium chlorohydrex-amino acid and a neutralizing salt. The particulate antiperspirant salt, when measured as an aqueous solution at a concentration of 15% by weight at 25° C., has a pH greater than 4.5, preferably about 4.6 to about 5.3. Also disclosed is a topical antiperspirant composition comprising the aforementioned particulate antiperspirant salt and a method of reducing perspiration from human skin by applying the aforementioned antiperspirant composition. In addition, there is disclosed a method of preparing the aforementioned particulate antiperspirant salt.Type: ApplicationFiled: June 30, 2005Publication date: January 4, 2007Inventors: Yanfei Shen, Stephen Provancal, Richard Oryszczak
-
Patent number: 6991780Abstract: Disclosed are enhanced efficacy aluminum-zirconium antiperspirant salt compositions that have a metal (Al+Zr) to chloride (or anion) ratio of about 0.90 to about 1.00. These salts also typically exhibit an HPLC peak 5 area content of about 33% or more, preferably at least 45%, more preferably at least 50%, most preferably at least 55%. Especially preferred are aluminum-zirconium antiperspirant salt compositions which, in addition to the aforementioned high peak 5 content, also exhibit an HPLC peak 4 to peak 3 area ratio of at least 0.4, preferably at least 0.7. Also disclosed are methods of making such antiperspirant salt compositions and aqueous solutions of such antiperspirant salt compositions. Further disclosed are topical compositions comprising a dermatologically acceptable carrier vehicle and a perspiration reducing effective amount of an aluminum-zirconium antiperspirant salt composition as described above.Type: GrantFiled: November 3, 2003Date of Patent: January 31, 2006Assignee: The Gillette CompanyInventors: Angel L. Carrillo, Richard Oryszczak, Yan-Fei Shen
-
Publication number: 20040136934Abstract: Disclosed are enhanced efficacy aluminum-zirconium antiperspirant salt compositions that have a metal (Al+Zr) to chloride (or anion) ratio of about 0.90 to about 1.00. These salts also typically exhibit an HPLC peak 5 area content of about 33% or more, preferably at least 45%, more preferably at least 50%, most preferably at least 55%. Especially preferred are aluminum-zirconium antiperspirant salt compositions which, in addition to the aforementioned high peak 5 content, also exhibit an HPLC peak 4 to peak 3 area ratio of at least 0.4, preferably at least 0.7. Also disclosed are methods of making such antiperspirant salt compositions and aqueous solutions of such antiperspirant salt compositions. Further disclosed are topical compositions comprising a dermatologically acceptable carrier vehicle and a perspiration reducing effective amount of an aluminum-zirconium antiperspirant salt composition as described above.Type: ApplicationFiled: November 3, 2003Publication date: July 15, 2004Applicant: The Gillette CompanyInventors: Angel L. Carrillo, Richard Oryszczak, Yan-Fei Shen
-
Patent number: 6663854Abstract: Disclosed are enhanced efficacy aluminum-zirconium chlorohydrate antiperspirant salts having a metal (Al+Zr) to chloride ratio of about 0.9 to about 1.2, preferably about 0.9 to about 1.1, most preferably about 0.9 to about 1.0. To achieve the highest possible antiperspirant efficacy, these salts are made with or include a zirconium hydroxychloride of the formula Zr(OH)4−bClb wherein b is about 2.8 to about 4.0, preferably about 3.2 to about 4.0, so that the Zr:Cl ratio in said zirconium hydroxychloride is about 0.36 to about 0.25, preferably about 0.31 to about 0.25. The present invention also embraces methods of making such antiperspirant salts and aqueous solutions of such antiperspirant salts. The present invention further embraces topical compositions comprising a dermatologically acceptable carrier and a perspiration reducing effective amount of an aluminum-zirconium antiperspirant salt as described above.Type: GrantFiled: June 19, 2002Date of Patent: December 16, 2003Inventors: Yan-Fei Shen, Richard Oryszczak, Angel L. Carrillo
-
Patent number: 6649152Abstract: Disclosed are enhanced efficacy aluminum-zirconium antiperspirant salt compositions which exhibit an HPLC peak 5 area content of about 33% or more, preferably at least 45%, more preferably at least 50%, most preferably at least 55%. Especially preferred are aluminum-zirconium antiperspirant salt compositions which, in addition to the aforementioned high peak 5 content, also exhibit an HPLC peak 4 to peak 3 area ratio of at least 0.4, preferably at least 0.7. The aforementioned salt compositions will preferably have a metal (Al+Zr) to chloride (or anion) ratio of about 0.90 to about 1.00. Also disclosed are methods of making such antiperspirant salt compositions and aqueous solutions of such antiperspirant salt compositions. Further disclosed are topical compositions comprising a dermatologically acceptable carrier vehicle and a perspiration reducing effective amount of an aluminum-zirconium antiperspirant salt composition as described above.Type: GrantFiled: May 3, 2002Date of Patent: November 18, 2003Assignee: The Gillette CompanyInventors: Angel L. Carrillo, Richard Oryszczak, Yan-Fei Shen
-
Publication number: 20030021757Abstract: Disclosed are enhanced efficacy aluminum-zirconium antiperspirant salt compositions which exhibit an HPLC peak 5 area content of about 33% or more, preferably at least 45%, more preferably at least 50%, most preferably at least 55%. Especially preferred are aluminum-zirconium antiperspirant salt compositions which, in addition to the aforementioned high peak 5 content, also exhibit an HPLC peak 4 to peak 3 area ratio of at least 0.4, preferably at least 0.7. The aforementioned salt compositions will preferably have a metal (Al+Zr) to chloride (or anion) ratio of about 0.90 to about 1.00. Also disclosed are methods of making such antiperspirant salt compositions and aqueous solutions of such antiperspirant salt compositions. Further disclosed are topical compositions comprising a dermatologically acceptable carrier vehicle and a perspiration reducing effective amount of an aluminum-zirconium antiperspirant salt composition as described above.Type: ApplicationFiled: May 3, 2002Publication date: January 30, 2003Applicant: The Gillette CompanyInventors: Angel L. Carrillo, Richard Oryszczak, Yan-Fei Shen
-
Patent number: 6436381Abstract: Disclosed are enhanced efficacy aluminum-zirconium antiperspirant salt compositions which exhibit an HPLC peak 5 area content of about 33% or more. Especially preferred are aluminum-zirconium antiperspirant salt compositions which, in addition to the aforementioned high peak 5 content, also exhibit an HPLC peak 4 to peak 3 area ratio of at least 0.4. The aforementioned salt compositions will preferably have a metal (Al+Zr) to chloride (or anion) ratio of about 0.90 to about 1.00. Also disclosed are methods of making such antiperspirant salt compositions and aqueous solutions of such antiperspirant salt compositions. Further disclosed are topical compositions comprising a dermatologically acceptable carrier vehicle and a perspiration reducing effective amount of an aluminum-zirconium antiperspirant salt composition as described above.Type: GrantFiled: October 25, 2000Date of Patent: August 20, 2002Assignee: The Gillette CompanyInventors: Angel L. Carrillo, Richard Oryszczak, Yan-Fei Shen
-
Patent number: 6126927Abstract: A method of making an antiperspirant powder is provided, including mixing a silicone rubber powder solution with an antiperspirant salt in a liquid carrier to form a uniform liquid mixture; and drying the liquid mixture to form an antiperspirant powder.Type: GrantFiled: June 19, 1998Date of Patent: October 3, 2000Assignee: The Gillette CompanyInventors: Stephen Provancal, Richard Oryszczak, Philip P. Angelone, Jr., Nancy M. Karassik
-
Patent number: 5939057Abstract: The present invention comprises a process of preparing a solution of an enhanced efficacy aluminum antiperspirant salt in a polyhydric alcohol by(a) providing an aqueous solution consisting essentially of about 5% to about 18% by weight of an enhanced efficacy aluminum antiperspirant salt in water, the enhanced efficacy aluminum antiperspirant salt having been prepared in situ without having been dried to a solid powder;(b) mixing the aqueous solution with a sufficient amount of a liquid polyhydric alcohol to provide a mixed solution which has an antiperspirant salt to polyhydric alcohol ratio of about 1:4 to about 1.2:1; and(c) rapidly evaporating the water from the mixed solution under vacuum to provide a final liquid polyhydric alcohol solution containing about 20 to 50% enhanced efficacy aluminum antiperspirant salt and about 2 to 16% water, with the balance being polyhydric alcohol.Type: GrantFiled: June 13, 1997Date of Patent: August 17, 1999Inventors: Stephen J. Provancal, Angel L. Carrillo, Thomas J. Fluhler, Richard Oryszczak, Jayant N. Sane
-
Patent number: 5643558Abstract: The present invention comprises a process of preparing a solution of an enhanced efficacy aluminum antiperspirant salt in a polyhydric alcohol by(a) providing an aqueous solution consisting essentially of about 5% to about 18% by weight of an enhanced efficacy aluminum antiperspirant salt in water, the enhanced efficacy aluminum antiperspirant salt having been prepared in situ without having been dried to a solid powder;(b) mixing the aqueous solution with a sufficient amount of a liquid polyhydric alcohol to provide a mixed solution which has an antiperspirant salt to polyhydric alcohol ratio of about 1:4 to about 1.2:1; and(c) rapidly evaporating the water from the mixed solution under vacuum to provide a final liquid polyhydric alcohol solution containing about 20 to 50% enhanced efficacy aluminum antiperspirant salt and about 2 to 16% water, with the balance being polyhydric alcohol.Type: GrantFiled: March 2, 1995Date of Patent: July 1, 1997Assignee: The Gillette CompanyInventors: Stephen J. Provancal, Angel L. Carrillo, Thomas J. Fluhler, Richard Oryszczak, Jayant N. Sane